Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit

Ana Isabel De Santiago-Díaz , Teresa Pérez-Poo , Erika Pindado-Jiménez , Gabriela Cortez-Astudillo , Aranzazu Zabala-Alonso , Elsa Gómez-Ruiz

Exploration of Neuroprotective Therapy ›› 2023, Vol. 3 ›› Issue (5) : 268 -280.

PDF (2495KB)
Exploration of Neuroprotective Therapy ›› 2023, Vol. 3 ›› Issue (5) :268 -280. DOI: 10.37349/ent.2023.00051
Original Article
research-article
Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit
Author information +
History +
PDF (2495KB)

Abstract

Aim: The present study aims to analyze the impact on cognitive recovery of an interdisciplinary treatment for acute and severe psychiatric patients. Methods: The present research is a naturalistic observational study of 130 adults (mean age of 47.68 years, 68% women). Clinical severity was assessed using Brief Psychiatry Rating Scale (BPRS), Montgomery-Asberg Depression Rating Scale (MADRS), and Hamilton Anxiety Rating Scale (HARS). Functional performance was evaluated using the Functioning Assessment Short Test (FAST), and cognitive impairment by applying the Montreal Cognitive Assessment (MoCA). Patients were clustered into four diagnostic groups (non-affective psychosis, bipolar, depressive, and personality disorders) and had individualized psychopharmacological treatment. They receive a transdiagnostic group program including several interventions that have shown evidence of beneficial effects over the different cognitive domains impaired in mental illness (attention, speed of processing, memory, working memory, reasoning, and problem-solving), as well as social cognition domains (emotion processing and social skills), in combination with psychoeducation and some strategies oriented to achieve healthy lifestyle routines (balanced diet, physical exercise, sleep hygiene, and smoking and alcohol cessation). Results: All clinical scales scores were improved after the end of treatment compared with those achieved at admission (BPRS, MADRS, and HARS scores below the cut-off point for establishing a case diagnosis). MoCA scores improved after the end of treatment concerning admission, both in the total score and in the differentiated cognitive domains, excluding orientation, which remained unchanged in the whole of the sample studied. No statistical significance was found in any comparisons between different diagnostic groups. No correlation between MoCA scores and BPRS, MADRS, or HARS scores at admission or discharge was found. Conclusions: These results show that the interdisciplinary therapeutic intervention can be effective for recovering cognitive impairment associated with mental disorders, irrespective of the diagnosis.

Keywords

Cognitive impairment / cognitive recovery / cognition / psychiatric disorder / transdiagnostic / clinical interventions

Cite this article

Download citation ▾
Ana Isabel De Santiago-Díaz, Teresa Pérez-Poo, Erika Pindado-Jiménez, Gabriela Cortez-Astudillo, Aranzazu Zabala-Alonso, Elsa Gómez-Ruiz. Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit. Exploration of Neuroprotective Therapy, 2023, 3 (5) : 268-280 DOI:10.37349/ent.2023.00051

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Mental illness [Internet]. Bethesda (MD): National Institute of Mental Health; [cited 2022 Sep 12]. Available from: https://www.nimh.nih.gov/health/statistics/mental-illness

[2]

Morozova A, Zorkina Y, Abramova O, Pavlova O, Pavlov K, Solovevа K, et al. Neurobiological highlights of cognitive impairment in psychiatric disorders. Int J Mol Sci. 2022; 23: 1217.

[3]

Nakagome K. Cognitive impairment in psychiatric disorders. Psychiatry Clin Neurosci. 2017; 71: 293.

[4]

Bora E, Yücel M, Pantelis C. Cognitive impairment in affective psychoses: a meta-analysis. Schizophr Bull. 2010; 36: 112-25.

[5]

Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br J Psychiatry. 2009; 195: 475-82.

[6]

MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. Psychiatry Clin Neurosci. 2017; 71: 18-27.

[7]

McCleery A, Nuechterlein KH. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations. Dialogues Clin Neurosci. 2019; 21: 239-48.

[8]

Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, et al. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull. 2009; 35: 1022-9.

[9]

Zhu Y, Womer FY, Leng H, Chang M, Yin Z, Wei Y, et al. The relationship between cognitive dysfunction and symptom dimensions across schizophrenia, bipolar disorder, and major depressive disorder. Front Psychiatry. 2019; 10: 253.

[10]

Solé B, Jiménez E, Torrent C, Reinares M, Del Mar Bonnin C, Torres I, et al. Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol. 2017; 20: 670-80.

[11]

Tsapekos D, Strawbridge R, Cella M, Wykes T, Young AH. Cognitive impairment in euthymic patients with bipolar disorder: prevalence estimation and model selection for predictors of cognitive performance. J Affect Disord. 2021; 294: 497-504.

[12]

Bourne C, Aydemir Ö, Balanzá-Martínez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013; 128: 149-62.

[13]

Daniel BD, Montali A, Gerra ML, Innamorati M, Girardi P, Pompili M, et al. Cognitive impairment and its associations with the path of illness in affective disorders: a comparison between patients with bipolar and unipolar depression in remission. J Psychiatr Pract. 2013; 19: 275-87.

[14]

Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014; 44: 2029-40.

[15]

Mihaljeviü-Peleš A, Bajs Janović M, Šagud M, Živkoviü M, Janoviü Š, Jevtović S. Cognitive deficit in schizophrenia: an overview. Psychiatr Danub. 2019; 31: 139-42.

[16]

Vita A, Gaebel W, Mucci A, Sachs G, Erfurth A, Barlati S, et al. European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia. Eur Psychiatry. 2022; 65: e58.

[17]

Helzer JE, Kraemer HC, Krueger RF. The feasibility and need for dimensional psychiatric diagnoses. Psychol Med. 2006; 36: 1671-80.

[18]

Ruggero CJ, Kotov R, Hopwood CJ, First M, Clark LA, Skodol AE, et al. Integrating the Hierarchical Taxonomy of Psychopathology (HiTOP) into clinical practice. J Consult Clin Psychol. 2019; 87: 1069-84.

[19]

Dalgleish T, Black M, Johnston D, Bevan A. Transdiagnostic approaches to mental health problems: current status and future directions. J Consult Clin Psychol. 2020; 88: 179-95.

[20]

Guía de Gestión del hospital de día psiquiátrico [Internet]. Madrid: Instituto Nacional de Gestión Sanitaria; c2020 [cited 2022 Nov 25]. Available from: https://ingesa.sanidad.gob.es/bibliotecaPublicaciones/publicaciones/internet/psiquiatrico.htm

[21]

Vázquez Bourgon J, Lastra IL, Artal Simón J, Crespo Facorro B, Vázquez-Barquero JL. Plan Funcional de la Unidad de Hospitalización Psiquiátrica Parcial. Servicio de Psiquiatría, Hospital Universitario Marqués de Valdecilla, editors. Santander: Imprenta Regional del Gobierno de Cantabria; 2014. Spanish.

[22]

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134: 382-9.

[23]

Lobo A, Chamorro L, Luque A, Dal-Ré R, Badia X, Baró E, et al. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin (Barc). 2002; 118: 493-9. Spanish.

[24]

Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133: 429-35.

[25]

Colom F, Vieta E, Martínez-Arán A, Garcia-Garcia M, Reinares M, Torrent C, et al. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med Clin (Barc). 2002; 119: 366-71. Spanish.

[26]

Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32: 50-5.

[27]

Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962; 10: 799-812.

[28]

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53: 695-9.

[29]

Ojeda N, del Pino R, Ibarretxe-Bilbao N, Schretlen DJ, Peña J. Montreal cognitive assessment test: normalization and standardization for Spanish population. Rev Neurol. 2016; 63: 488-96. Spanish.

[30]

Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Heal. 2007; 3: 5.

[31]

Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988; 24: 653-9.

[32]

Brooks R ; EuroQol Group. EuroQol: the current state of play. Health Policy. 1996; 37: 53-72.

[33]

Badia X, Monserrat S, Roset M, Herdman M. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res. 1999; 8: 303-10.

[34]

Shafer A. Meta-analysis of the Brief Psychiatric Rating Scale factor structure. Psychol Assess. 2005; 17: 324-35.

[35]

Subdirección General de Información Sanitaria. Salud mental en datos: prevalencia de los problemas de salud y consumo de psicofármacos y fármacos relacionados a partir de registros clínicos de atención primaria. Madrid: Ministerio de Sanidad; 2021. Spanish.

PDF (2495KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉